Methods of administering elagolix | Patent Number 11690845

US 11690845 B2
Application Number17004817
Publication NumberUS 20210275527 A1
Pendency2 years, 10 months, 11 days
Filled DateAug 27, 2020
Priority DateMar 5, 2020
Publication DateSep 9, 2021
Expiration DateMar 4, 2040
Inventor/ApplicantsAkshanth R. Polepally
Farah N. Ali
Ahmed Nader
Nael M. Mostafa
Sheetal P. Dharia
Mohamad Shebley
ExaminesHUI, SAN MING R
Art Unit1627
Technology Center1600
Assignments
Abbvie Inc.
Current
Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.